Citigroup’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $57.5K | Buy |
|
|||||
|
2025
Q2 | $140K | Sell |
|
|||||
|
2025
Q1 | $829K | Buy |
|
|||||
|
2024
Q4 | $65.6K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $139K | Buy |
|
|||||
|
2023
Q3 | $1.82K | Sell |
|
|||||
|
2023
Q2 | $30.8K | Sell |
|
|||||
|
2023
Q1 | $1.65M | Sell |
|
|||||
|
2022
Q4 | $1.75M | Buy |
|
|||||
|
2022
Q3 | $1.27M | Hold |
|
|||||
|
2022
Q2 | $835K | Buy |
|